Although the molecular mechanism remains elusive, a subset of ICF patients exhibit lymphopenia and/or an inverted CD4+/CD8+ ratio due to the reduction of CD4+ T-cells, which potentially hampers activation of naïve B-cells and CSR (Figure 2). Here, CD4 is linked to lymphopenia.